Growing Capacity Metrion Biosciences has recently expanded its facilities at Granta Park in Cambridge, doubling laboratory space and increasing capacity for high-throughput ion channel screening and drug discovery projects. This presents an opportunity to offer scaled-up testing and complementary services to their increased client base.

Leadership & Innovation With over 125 years of combined drug discovery experience and a strong focus on ion channel research, Metrion is positioned as a leader in preclinical screening. Collaborating with their expert team can open avenues for advanced assay development and novel protocol integrations.

Industry Recognition Winning awards for their sales and marketing campaigns highlights Metrion’s reputation for strategic outreach and innovative project promotion. Leveraging this visibility can help introduce new partner solutions and expand project scope within their network.

Recent Hires & Growth The addition of senior personnel such as Tom Ashmore indicates ongoing strategic growth in business development efforts, especially across Europe. Tailoring outreach to support their expansion plans and new partnership channels could facilitate further commercial opportunities.

Market Positioning Operating within a competitive yet specialized niche in biotech CRO services with a revenue range of 1 to 10 million, Metrion actively seeks collaborations in ion channel research, neuroscience, and cardiac safety. Targeting these domains with specific assay, technology, or consultancy services can enhance sales engagement.